Connecting for innovation and impact for all in global health

contact us
Membership
Subscribe

Search

Asia
MEMBERS
Show Members
TOPICS
REGIONS
JPM 2026 | From Products to Patients: Capturing Value in Asia and Africa’s Growth Markets

JPM 2026 | From Products to Patients: Capturing Value in Asia and Africa’s Growth Markets

For the third consecutive year, the Alliance convened a panel at the 2026 J.P. Morgan Healthcare Conference (JPM) in San Francisco, followed by an Alliance side meeting held at Accenture’s San Francisco Innovation Hub. This year’s panel brought together leaders from Gilead Sciences, U.S. Development Finance Corporation (DFC), Nivi, Inc., reach52, and Accenture to explore how pharmaceutical partnerships, development finance, and patient platforms are creating investable infrastructure in high-growth markets across Asia and Africa. The panel underscored that the most promising long-term opportunities in emerging markets lie not just in individual products, but in the systems and partnerships that connect them to patients.

Contextual Bias, AI, and Innovation in Healthcare | Dr. Maryam Mustafa

Contextual Bias, AI, and Innovation in Healthcare | Dr. Maryam Mustafa

,

Dr. Maryam Mustafa brings insight into data biases in the age of AI and their impact, her learnings on what equitable AI technologies might look like and how to innovate in complex contexts to serve the most vulnerable and marginalized communities. She will share her experience developing Awaz-e-Sehat— a startup that leverages AI technologies to improve women’s intimate and reproductive health in Pakistan.

From the Innovators Workbench: Biodesign in India

From the Innovators Workbench: Biodesign in India

,

Join Stanford Biodesign to hear from two of the Stanford-India Biodesign initiative’s architects and an early alumna. How did they lay the groundwork for the program? What are the opportunities and challenges inherent in a collaboration with the government? How did the need for cost-effective technologies influence the innovation approach? And how did they catalyze the work of funders, suppliers, manufacturers, distributors, and purchasers required to get the inventions to patients? They will discuss their biggest takeaways from this entrepreneurial endeavor, the potential to replicate it in other resource-constrained environments, and what excites them most about the future of healthtech innovation in India.